A - חוב לטווח קצר להון Agilent Technologies

The history of the short interest ratio confirms the resilience of Agilent Technologies (A), which relies on a global installed base of instruments and high-margin services. The value of 0.01 serves as a baseline indicator of financial maturity amid expectations for a recovery in biotech demand, which the market currently prices in. Dominance in biopharma and the growth of cancer diagnostics ensure stability through recurring customer payments.

Agilent Technologies (A) is scaling the production of laboratory systems amid volatile demand from the biotech sector. This chart of the ratio between short-term liabilities and equity captures the share of obligations with maturities exceeding one year, determining the company's financial leverage. The current value of 0.01 allows for a real-time assessment of the business's dependence on borrowed capital under macroeconomic pressure from China. An increase in this indicator may enhance returns, but it raises the risk of asset drawdowns if client capital expenditures decline.